CSat Investment Advisory, L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
CSat Investment Advisory, L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2020$32,000
+10.3%
370
+14.9%
0.00%
-25.0%
Q2 2020$29,000
+163.6%
322
+187.5%
0.00%
+100.0%
Q1 2020$11,000
+10.0%
112
+25.8%
0.00%
-33.3%
Q4 2019$10,000
-94.6%
89
-93.9%
0.00%
-94.8%
Q3 2019$184,000
+28.7%
1,457
+22.6%
0.06%
+13.7%
Q2 2019$143,0001,1880.05%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders